ライフサイエンスコーパス: Galphai

1 nucleotide, and helical domain interfaces of Galphai.

2 egulation of MUC1 and TNFalpha by regulating Galphai.

3 e motif that allows it to serve as a GEF for Galphai.

4 guanine nucleotide exchange factor (GEF) for Galphai.

5 duction of nuclear factor (NF)kappaB through Galphai.

6 hemical signals) by activating the G protein Galphai.

7 s phototransduction primarily by coupling to Galphai.

8 in favour of fibrosis, all via activation of Galphai.

9 ines located within the interdomain cleft of Galphai.

10 abolishes GIV's ability to bind and activate Galphai.

11 1 and the extreme C-terminal helix alpha5 of Galphai.

12 with the extreme C-terminal helix alpha5 of Galphai.

13 or not CCR5 is coupled to G proteins such as Galphai.

14 armacological doses of apelin acting through Galphai.

15 leotide exchange factor motif that activates Galphai.

16 defined protein sequence that directly binds Galphai.

17 iated through the nonclassical inhibitory G (Galphai/0) protein.

18 one endophenotype (FG2) with phosphorylated Galphai(1) and Galphai(2) was consistently associated wi

19 ollectively, these data demonstrate that PVN Galphai(2) protein pathways play an endogenous role in m

20 Consequently, we examined the role of brain Galphai(2) proteins in the neural mechanisms facilitatin

21 ent high salt-induced up-regulation of brain Galphai(2) proteins, animals exhibited sodium retention,

22 tide (ODN)-mediated down-regulation of brain Galphai(2) proteins, but not a scrambled ODN, abolished

23 ficiency) or increase (sodium excess) in PVN Galphai(2) proteins; plasma norepinephrine levels were i

24 ype (FG2) with phosphorylated Galphai(1) and Galphai(2) was consistently associated with a significan

25 We have demonstrated that brain Galphai(2)-subunit protein pathways mediate the natriure

26 and stabilize the GDP-bound conformation of Galphai, acting as guanine nucleotide dissociation inhib

27 CXCL10 displayed full agonistic activity for Galphai activation and extracellular signal regulated ki

28 ide a novel and versatile tool to manipulate Galphai activation downstream of growth factors in a div

29 g ligand efficiency [log(tau/KA)] to promote Galphai activation, as well as with ligand ability to pr

30 rowth factor receptors and for activation of Galphai after growth factor stimulation.

31 We also observed that H1R activates Galphai, albeit at a 10-fold lower potency.

32 ross-link between K5.64(215) in TMH5 and the Galphai alpha4beta6 loop residue, Lys-317.

33 We now report that LGN and Galphai also occupy the very tip of stereocilia that dir

34 ange factor (GEF) for the trimeric G protein Galphai and a bona fide metastasis-related gene that ser

35 adrenergic receptor density and increases in Galphai and beta-adrenergic receptor kinase activities a

36 CCR1 concurrently engages Galphai and beta-arrestin-2 in a multiprotein complex, w

37 oes not affect cAMP signals mediated through Galphai and betaAR.

38 ulatory (GPR) motif peptide in AGS3 binds to Galphai and downregulates MUC1 expression; in contrast,

39 energy transfer studies and found that eYFP-Galphai and eCFP-Gbetagamma remain associated after stim

40 Whereas apelin stimulates APJ to activate Galphai and elicits a protective response, stretch signa

41 Thus, Daple activates Galphai and enhances non-canonical Wnt signaling by FZDR

42 hen Ser1674 is phosphorylated, GIV activates Galphai and enhances promigratory Akt signals.

43 vation through recruiting G protein subunits Galphai and Galpha12 to activate PKCbeta/CARMA1/TRAF6/NE

44 xin uncoupling-based studies have shown that Galphai and Galphao can inhibit insulin secretion in pan

45 Yet it is unclear whether Galphai and Galphao operate through identical mechanisms

46 rol, expression of TGR5 and Galphas (but not Galphai and Galphaq ) proteins was increased 2-fold to 3

47 Upon EGF stimulation, GIV modulates Galphai and Galphas sequentially: first, a key phosphomo

48 s of dual coupling of GIV to two G proteins, Galphai and Galphas, remained unknown.

49 lling platform comprising G protein subunit, Galphai and GIV, its guanine exchange factor (GEF), whic

50 onstitutive signaling activity via G protein Galphai and induced activation of the NF-kappaB transcri

51 Phosphorylation triggers the activation of Galphai and inhibits second messengers (cAMP).

52 B2R), as well as a significant population of Galphai and its coupled beta2-adrenergic receptor (betaA

53 n, and all of these events were dependent on Galphai and Jnk1, two downstream mediators of Ltb4r1 sig

54 es a conformationally heterogeneous state of Galphai and provide insight into the mechanism of action

55 ted growth inhibition involves activation of Galphai and suppression of MAPK signaling.

56 ic association of ligand-activated RTKs with Galphai, and for noncanonical transactivation of G prote

57 is necessary for palmitoylation of Galphas, Galphai, and functional responses downstream of beta-adr

58 -dependent signaling bias among the Galphas, Galphai, and Galphaq/11 pathways.

59 igand-activated ternary complex between GIV, Galphai, and growth factor receptors and for activation

60 imarily coupled to the inhibitory G protein, Galphai, and has been shown to modulate the resolution o

61 ong with basic residues at the N-terminus of Galphai, and suggests that activated G protein-coupled r

62 different receptor types, cross-talk between Galphai- and Galphaq-coupled receptors is often thought

63 We demonstrate that LGN and Galphai are both essential for promoting the elongation

64 urified components revealed that Galphas and Galphai are direct substrates of DHHC5.

65 e propose that activated ERMs, together with Galphai, are critical for the correct localization of LG

66 lphai depalmitoylation and enhanced receptor-Galphai association.

67 ne-nucleotide exchange modulator dissociates Galphai*betagamma trimers, scaffolds monomeric Galphai w

68 conformational changes as naltrexone at the Galphai-betagamma interface, whereas it appears as an in

69 ally, our data characterize Gue1654 as a non-Galphai-biased antagonist of OXE-R that provides a new b

70 Pins contains three Galphai binding GoLoco domains (GLs); Galphai binding to

71 three Galphai binding GoLoco domains (GLs); Galphai binding to GL3 activates Pins, whereas GLs 1 and

72 tress fibre signalling by increasing Smo and Galphai binding.

73 gned a battery of GIV mutants with different Galphai-binding and -activating properties and used it t

74 phila Pins (Partner of Inscuteable) (LGN), a Galphai-binding protein that is critical for spindle pos

75 metastasis and disruption of its binding to Galphai blunts the pro-metastatic behavior of cancer cel

76 ls, on the other hand, remained dependent on Galphai, but required the presence of antigen-specific e

77 Activation of Galphai by GIV-GEF further potentiates FAK-GIV-PI3K-Akt

78 equires activation of the trimeric G protein Galphai by the nonreceptor guanine nucleotide exchange f

79 ross-link between C3.53(134) in TMH3 and the Galphai C-terminal i-3 residue Cys-351; 2) a lysine cros

80 ross-link between K6.35(245) in TMH6 and the Galphai C-terminal i-5 residue, Lys-349; and 3) a lysine

81 switch that modulates TLR4 signaling via the Galphai/c-Raf/MEK/ERK signaling axis in human macrophage

82 Galphai/c-Raf/MEK/ERK signaling induced by C5a was ampli

83 DAMGO evoke similar SPR signatures and that Galphai, cAMP-dependent pathways, and ERK1/ERK2 have key

84 ry complex, it is not known if Galphaolf and Galphai can bind to AC5 simultaneously, nor what activit

85 endothelial integrity is mediated by a S1PR1-Galphai-Cdc42 pathway.

86 unction through S1PR1-Galphai-Rac1 and S1PR1-Galphai-Cdc42 pathways.

87 uits peroxiredoxin 6 (PRDX6) to the receptor-Galphai complex by c-Jun N-terminal kinase, resulting in

88 osphomodification favors the assembly of GIV-Galphai complexes and activates GIV's GEF function; then

89 Preassembled CB1-Galphai complexes were detected by BRET(2) Arachidonyl-2

90 r175 at the level of PKA and upstream of the Galphai component of heterotrimeric G proteins, which it

91 both Galphas and Galphaq but also identify a Galphai component to CLR signaling in both yeast and HEK

92 protein Mud (NuMA) occurs over a very narrow Galphai concentration range.

93 Galphai constructs labeled within the helical domain (Ga

94 Although chemotaxis via Galphai coupled-receptors has been implicated in PC migr

95 tant viruses use the inhibitor-bound form of Galphai-coupled CCR5 more efficiently than they use unco

96 and instead was mediated through additional Galphai-coupled chemoattractant receptor pathways, inclu

97 Galphai-coupled chemoattractant receptors, such as the 5

98 gration - are dependent on the activation of Galphai-coupled chemokine receptors on T cells.

99 Originally thought to belong to the Galphai-coupled ciliary opsins, xenopsins are now unders

100 hese studies reveal a non-redundant role for Galphai-coupled CXCR3 in stabilizing intravascular adhes

101 To this end, we expressed the Galphai-coupled designer receptor hM4D in adult striatop

102 atants identified CXCL10, CXCL8, and CCL5 as Galphai-coupled receptor agonists of potential interest.

103 om a classical Galphas-coupled receptor to a Galphai-coupled receptor stabilizing a distinct receptor

104 blasts with pertussis toxin, an inhibitor of Galphai-coupled receptors, prevented their migration.

105 mechanism of signal integration between the Galphai-coupled type I cannabinoid receptor (CB(1)R) and

106 arinic acetylcholine receptor expression and Galphai coupling and enhanced M3 subtype of muscarinic a

107 lex by c-Jun N-terminal kinase, resulting in Galphai depalmitoylation and enhanced receptor-Galphai a

108 dent PRDX6 recruitment and oxidation-induced Galphai depalmitoylation as an additional mechanism of G

109 Selective inhibition of PRDX6 blocks Galphai depalmitoylation, prevents the enhanced receptor

110 ouse EARs in response to CCL11 and CCL24 was Galphai -dependent.

111 This phosphorylation event involves both Galphai-dependent and -independent pathways, and is cons

112 his dephosphorylation event depends upon the Galphai-dependent engagement of specific members of the

113 reduced the EMax and pEC50 of ACEA-mediated Galphai-dependent ERK phosphorylation.

114 -green fluorescent protein 2 (GFP(2)), and a Galphai-dependent increase in ERK phosphorylation.

115 iral infection or local cell death, triggers Galphai-dependent intravascular retention of Ly6C(low) m

116 ase activating proteins (GAPs) for GTP-bound Galphai, downstream of Smo.

117 phosphorylation by PKA, a classical Galphas/Galphai effector.

118 GDP-Galphai nucleotide exchange, decreasing Galphai expression, pharmacologically interrupting Gbeta

119 ss high binding affinities for CXCR4 and are Galphai full agonists with robust chemotactic properties

120 states for CCR1; whereas receptor coupled to Galphai functions as a canonical GPCR, albeit with high

121 palmitoylation as an additional mechanism of Galphai-G-protein-coupled receptor inactivation.Opioid r

122 d regulators, including G proteins (Galphas, Galphai, Galphao, Gbetagamma), protein kinases (PKCbetaI

123 as a guanine nucleotide exchange factor for Galphai, Galphaq, and Galpha12/13 and as a molecular cha

124 Galphai, Galphaq, and Galpha13, but not Galphas produced

125 GDP-AlF4(-)-bound Galphai, Galphaq, Galpha13, and Galphas produced in mock

126 Interactions between CB1 and D2L, Galphai, Galphas, and beta-arrestin1 were studied using

127 ctional roles through their interaction with Galphai, Galphat, and Galphao via a G-protein regulatory

128 Importantly, NF023 did not disrupt Galphai-Gbetagamma binding, indicating its specificity t

129 +) promoted GPCR-independent dissociation of Galphai(GDP) from Gbetagamma by a Mg(2+)-independent mec

130 hen bound to GTP, key cellular functions for Galphai-GDP are beginning to emerge.

131 embrane localization is regulated by binding Galphai-GDP, whereas RGS14 nuclear export is regulated b

132 lthough this suggests that inhibition of the Galphai-GIV interaction is a promising therapeutic strat

133 py and biochemical assays, overlaps with the Galphai-GIV interface.

134 Here, we set out to investigate whether Galphai-GIV is a druggable PPI.

135 This work establishes the Galphai-GIV PPI as a druggable target and sets the conce

136 sted a collection of >1,000 compounds on the Galphai-GIV PPI by in silico ligand screening and separa

137 cells expressing a GEF-deficient mutant, the Galphai-GIV-EGFR signaling complex is not assembled, EGF

138 a binding, indicating its specificity toward Galphai-GIV.

139 Agonist regulation of the receptor-Galphai-GPR complex was also confirmed by coimmunoprecip

140 t by WT Galphai1 expression, suggesting that Galphai-GTP also regulates adhesion in immune cells at t

141 These data identify a novel role of Galphai-GTP in regulation of cell adhesion and migration

142 This indicates that adhesion regulation by Galphai-GTP occurs downstream of Rap1a and Radil, but is

143 nce between Gbetagamma-promoted adhesion and Galphai-GTP reversal of adhesion is important for this p

144 lly propagate to the hydrophobic core of the Galphai GTPase domain.

145 ly, our findings offers a new perspective on Galphai hypofunctionality in a human disease by revealin

146 Importantly, Galphai immunoprecipitation and calcium mobilization stu

147 ng the palmitoylation of receptor-associated Galphai in a JNK-dependent manner.

148 monstrate a previously unrecognized role for Galphai in beta1AR signaling and suggest that the concep

149 present a 2.0- angstrom crystal structure of Galphai in complex with the GEM motif of GIV/Girdin.

150 triggers GIV's ability to bind and activate Galphai in response to growth factors and modulate downs

151 h VAV1 mediating Rho activation by JAKs in a Galphai-independent manner.

152 was mediated through both PAR1 and PAR4 in a Galphai-independent signaling pathway.

153 The discovery of a dramatic decrease in Galphai inhibition of AC activity after SCI is novel for

154 uman AC9 reported that AC9 is insensitive to Galphai inhibition.

155 Accordingly, the Galphai inhibitor pertussis toxin and MEK inhibitor U012

156 s signaling stimulates PKA activity, whereas Galphai inhibits PKA activity.

157 e we describe the identification of GINIP, a Galphai-interacting protein expressed in two distinct su

158 on and migration via ERalpha, direct ERalpha-Galphai interaction, and endothelial NOS (eNOS) activati

159 map the cannabinoid receptor subtype 2 (CB2)-Galphai interface and then used molecular dynamics simul

160 Recruitment of Galphai is not induced by any other betaAR ligand screen

161 omplexes are formed in living cells and that Galphai is transactivated within minutes after growth fa

162 ation of Drosophila Pins (LGN in mammals) by Galphai is ultrasensitive (apparent Hill coefficient of

163 ange factor (GEF) for the trimeric G protein Galphai, is another major hierarchical conduit for the m

164 The three Galphai isoforms exhibited a selective serine phosphoryl

165 pecific serine phosphorylation signatures of Galphai isoforms that may facilitate the identification

166 onstructs labeled within the helical domain (Galphai-L91-YFP) largely do not dissociate upon activati

167 t to act as local cues that pattern cortical Galphai, LGN, and nuclear mitotic apparatus protein (NuM

168 le orientation is regulated by the conserved Galphai-LGN-NuMA complex, which targets the force genera

169 and astral microtubule-mediated transport of Galphai/LGN/nuclear mitotic apparatus (NuMA) complex fro

170 nts counteract such transport by maintaining Galphai/LGN/NuMA and dynein at the cell cortex.

171 the cell cortex by two distinct pathways: a Galphai/LGN/NuMA-dependent pathway and a 4.1G/R and NuMA

172 of individual signaling pathways, e.g., the Galphai-mediated and the arrestin-mediated pathways for

173 on and loss of barrier function, but only if Galphai-mediated signaling is suppressed.

174 hereas constitutive activity was observed in Galphai-mediated signaling.

175 mphoid tissues is a complex process in which Galphai-mediated signals play a decisive role.

176 xclusion of GIV's GEF motif, which activates Galphai, modulates EGFR signaling, generates migration-p

177 r proliferation/survival signaling and PAR-2-Galphai-NFkappaB inflammatory signaling.

178 Here, we report that Galphai nucleotide exchange and signaling helps macropha

179 lular Ca(2+) that was partially sensitive to Galphai nucleotide exchange inhibition and expression of

180 Reducing GDP-Galphai nucleotide exchange, decreasing Galphai expressi

181 raphe nucleus (DRN), feedback activation by Galphai/o -coupled 5-HT1A autoreceptors reduces the exci

182 cts indicate that the molecular mechanism of Galphai/o activation is affected by the presence and loc

183 ersed by pertussis toxin (PTX), which blocks Galphai/o activation.

184 amily of RGS proteins generally accepts both Galphai/o and Galphaq/11 subunits as substrates, the R7

185 sting fluorescently labeled and non-modified Galphai/o constructs indicate that the molecular mechani

186 In contrast, available Galphai/o decreases from ~2 to less than one Galpha per

187 n depends on coupling of opioid receptors to Galphai/o family members.

188 nally, by using mice deficient in individual Galphai/o G-protein subunits, we demonstrate that Galpha

189 mal stoichiometry of 4 Gbetagamma but only 2 Galphai/o per one GIRK1/2 channel.

190 eptor (GPCR), the activation of KOR promotes Galphai/o protein coupling and the recruitment of beta-a

191 norepinephrine, differences depended on the Galphai/o protein subunit involved.

192 d receptor-activity assays to characterize a Galphai/o protein-coupled receptor activated by BigLEN i

193 g that the dissociation seen in non-modified Galphai/o proteins is not required for downstream signal

194 duced insulin secretion, through Galphas and Galphai/o proteins, respectively.

195 n expression levels mainly by triggering the Galphai/o signaling pathway, which in turn leads to redu

196 signaling and osteoblast differentiation via Galphai/o signaling.

197 Constructs of Galphai/o subunits fluorescently labeled at the N termin

198 s included activation of G proteins with all Galphai/o subunits, adenylyl cyclase inhibition, and bet

199 ignaling through Galphaz compared with other Galphai/o subunits.

200 y reproduce the behavior of the non-modified Galphai/o subunits.

201 accelerating protein for Galphaz as well as Galphai/o subunits.

202 ing mechanisms involving Galpha12/13 but not Galphai/o These findings provide the first evidence that

203 t the engagement of the distal C-terminus of Galphai/o with the receptor differentiates primary and s

204 scently labeled at the N terminus (GAP43-CFP-Galphai/o) seem to faithfully reproduce the behavior of

205 ls is not dependent on inhibitory G protein (Galphai/o) signaling but rather Ca(2+) entry through a G

206 signal via Galpha proteins of the i/o class (Galphai/o), acutely regulate cellular behaviors widely i

207 ve to the reference compound WIN55,212-2 for Galphai/o, Galphas, Galphaq, Gbetagamma, and beta-arrest

208 y, although AC9 is not directly inhibited by Galphai/o, it can heterodimerize with Galphai/o-regulate

209 modulin kinase II (CaMKII) and inhibition by Galphai/o, novel PKC isoforms, or calcium-calcineurin.

210 Therefore, enhancing Galphai/o-biased endocannabinoid signaling may be therap

211 The Galphai/o-coupled dopamine D2-like receptor family compr

212 The Emax of Galphai/o-dependent extracellular signal-regulated kinas

213 protein signaling (RGS) domain binds active Galphai/o-GTP, whereas the C-terminal G protein regulato

214 ted by Galphai/o, it can heterodimerize with Galphai/o-regulated isoforms, AC5 and AC6.

215 or indirectly, particularly with respect to Galphai/o.

216 2-AG and AEA displayed Galphai/o/Gbetagamma bias and normalized CB1 protein lev

217 utation, and receptor coupling to endogenous Galphai/obetagamma was subsequently eliminated by cell t

218 activation appears independent of endogenous Galphai/obetagamma, suggesting that GalphaiAGS3 and Galp

219 SCI also reduces the negative regulation by Galphai of adenylyl cyclase and its production of cAMP,

220 of Gbetagamma, but not constitutively active Galphai or Galphao, inhibited TRPM3 currents.

221 ot be phosphorylated, GIV cannot bind either Galphai or Galphas, Akt signaling is suppressed, mitogen

222 gical inhibition of heterotrimeric G protein Galphai or PI3K signaling and siRNA targeting ESCRTs blo

223 is pathway did not involve cAMP, Galphas, or Galphai or the participation of the other members of the

224 ulation led to rapidly increased Galphas and Galphai palmitoylation.

225 We propose that LGN and Galphai participate in a long-inferred signal that origi

226 When the GIV-Galphai pathway is selectively inhibited, levels of GTP-

227 tein Mud independently of the classical Pins/Galphai pathway.

228 wth hormone secretagogue receptor subtype 1a-Galphai -PI3K-Erk1/2-KATP pathway.

229 ype resulting in a differential reduction in Galphai protein activity as determined by cellular diele

230 Interestingly, we also reveal that total LGN-Galphai protein amounts are actively balanced between th

231 d a comprehensive G protein-coupled receptor-Galphai protein chemical cross-linking strategy to map t

232 of apical membrane specified by the Insc-LGN-Galphai protein complex.

233 Both of these require heterotrimeric Galphai protein signaling, whose intensity and duration

234 PLC-beta2, PI3K, ERK, p38 and independent of Galphai protein, and neutrophil migration toward synovia

235 ts sensed by pertussis toxin (PTX)-sensitive Galphai protein-coupled receptors (GPCRs).

236 s through a cAMP-dependent pathway involving Galphai protein-coupled receptors.

237 and activating (GBA) motif, which activates Galphai proteins and an adjacent domain that directly bi

238 We propose a role for Galphai proteins and LGN in regulating the position-depe

239 Specifically, we tested the role of Galphai proteins and their binding partner LGN/Gpsm2 imp

240 feration via noncanonical transactivation of Galphai proteins by the guanine exchange factor (GEF) GI

241 The role of Galphai proteins coupled to chemokine receptors in direc

242 ssed by autoradiography on brain slices, and Galphai proteins expression was measured by western blot

243 lyl cyclase production of cAMP to inhibitory Galphai proteins in DRGs.

244 zing each endophenotype lies at the level of Galphai proteins leading to a systemic and generalized d

245 Galphai proteins play major roles in the developing and

246 Of the Galphai proteins that can couple with Smo, G protein alp

247 show that zymosan exposure recruits F-actin, Galphai proteins, and Elmo1 to phagocytic cups and early

248 irect platform for multiple RTKs to activate Galphai proteins.

249 by the stimulatory Galphaolf and inhibitory Galphai proteins.

250 es Galpha activity-inhibiting polypeptide 1 (Galphai) proteins in response to growth factors, such as

251 d endothelial barrier function through S1PR1-Galphai-Rac1 and S1PR1-Galphai-Cdc42 pathways.

252 which were mediated via ERK, PI3-kinase, and Galphai-Rac1 pathways.

253 hange inhibition and expression of GTP-bound Galphai recruited Elmo1 to the plasma membrane.

254 ytoplasmic dynein heavy chain (DYNC1H1) in a Galphai-regulated manner.

255 To uncover the mechanism for Galphai regulation of adhesion, we analyzed the effects

256 antagonist having no inhibitory activity on Galphai-related signaling, which makes Gue1654 an unprec

257 agocytosis, while favoring the duration that Galphai remained GTP bound promoted it.

258 etween canonical Hh-Gli and non-canonical Hh-Galphai-RhoA pathways and highlight IFT80 as a therapeut

259 localization, but elevates non-canonical Hh-Galphai-RhoA-stress fibre signalling by increasing Smo a

260 ntagonist, inhibited BRETEff signals between Galphai-Rluc and CB1-GFP(2) and reduced the EMax and pEC

261 ncrease in BRET efficiency (BRETEff) between Galphai-Rluc and CB1-green fluorescent protein 2 (GFP(2)

262 ased, while the inhibition of AC activity by Galphai showed an unexpected and dramatic decrease after

263 lpha-subunit of the heterotrimeric G-protein Galphai showed expected functionality in both chemical a

264 We highlight an absolute requirement for Galphai signaling and actin cytoskeletal rearrangement a

265 rawling on the blood vessel wall and require Galphai signaling in neutrophils.

266 ent work uncovered novel roles for activated Galphai signaling in the regulation of neutrophil polari

267 recently reported the regulation of the AGS3-Galphai signaling module by a cell surface, seven-transm

268 cal Ca(2+) imaging we analyzed IHCs in which Galphai signaling was blocked by Cre-induced expression

269 By contrast, inhibition of Galphai signaling with pertussis toxin affects speed but

270 on, we found that chemogenetic activation of Galphai signaling within CaMKIIalpha BLA neurons was suf

271 st that activation of the DYN/KOR system and Galphai signaling within the BLA is both necessary and s

272 receptor B leukotriene receptor 1 (BLT1) and Galphai signaling, increased macrophage expression of in

273 and that both steps occurred independent of Galphai signaling.

274 tment of 14-3-3 and inhibition of binding to Galphai, so the Pins falls off the cortex.

275 to CCR2, CCR5, and CCR7 activated the three Galphai subtypes (Galphai1, Galphai2, and Galphai3) and

276 T cells with pertussis toxin to uncouple the Galphai subunit from CCR5 increased the potency of VVC a

277 ceptors, triggering heterotrimeric G protein Galphai subunit guanine nucleotide exchange.

278 esponse evoked by MC1R via activation of the Galphai subunit of G proteins, thus decreasing cellular

279 large G-protein complexes which contain the Galphai subunit.

280 clude that chemoattractant receptors require Galphai subunits only as adaptors to transactivate the G

281 RGS proteins limit the duration that Galphai subunits remain GTP bound, and the loss of an in

282 ion and endocrine cell specification rely on Galphai subunits, revealing an unexpected specificity of

283 e generators, are recruited to the cortex by Galphai-subunits of heterotrimeric G-proteins.

284 sensors provide direct evidence that RTK-GIV-Galphai ternary complexes are formed in living cells and

285 s engineered by introducing modifications in Galphai that preclude coupling to every known major bind

286 bunit Repo-Man, but it acts independently of Galphai, the kinase Aurora A, and the phosphatase PP2A.

287 -3 binding inhibits association of Pins with Galphai, through which Pins attaches to the cortex.

288 rectional cell migration, but few links from Galphai to chemotactic effectors are known.

289 l to D2 receptors switched CB1 coupling from Galphai to Galphas In addition, haloperidol treatment re

290 ng of type 1 cannabinoid receptor (CB1) from Galphai to Galphas, a process thought to be mediated thr

291 g pathways most likely involving Galphaq and Galphai to induce degranulation.

292 (CXCL8) receptors CXCR1 and CXCR2 couple to Galphai to induce leukocyte recruitment and activation a

293 mokine receptors, CXCR1 and CXCR2, couple to Galphai to induce leukocyte recruitment and activation a

294 n activation of the heterotrimeric G-protein Galphai to regulate directional cell migration, but few

295 guanine-nucleotide exchange factor (GEF) for Galphai, to serve as a direct platform for multiple RTKs

296 as blocked by pertussis toxin, implicating a Galphai-triggered signal pathway.

297 The H3R and H4R activated Galphai with high specificity and a high potency.

298 and manipulating the dynamic association of Galphai with RTKs for noncanonical transactivation of G

299 lphai*betagamma trimers, scaffolds monomeric Galphai with RTKs, and facilitates the phosphorylation o

300 es, suggesting that Gbeta1gamma2 may bind to Galphai without a significant change in orientation.